66 related articles for article (PubMed ID: 10631098)
1. Identification of an ApoA-I ligand domain that interacts with high-affinity binding sites on HepG2 cells.
Georgeaud V; Garcia A; Cachot D; Rolland C; Tercé F; Chap H; Collet X; Perret B; Barbaras R
Biochem Biophys Res Commun; 2000 Jan; 267(2):541-5. PubMed ID: 10631098
[TBL] [Abstract][Full Text] [Related]
2. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles.
Sviridov D; Pyle L; Fidge N
Biochemistry; 1996 Jan; 35(1):189-96. PubMed ID: 8555173
[TBL] [Abstract][Full Text] [Related]
3. Remnant high density lipoprotein2 particles produced by hepatic lipase display high-affinity binding and increased endocytosis into a human hepatoma cell line (HEPG2).
Guendouzi K; Collet X; Perret B; Chap H; Barbaras R
Biochemistry; 1998 Oct; 37(42):14974-80. PubMed ID: 9778375
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein 3 receptor-dependent endocytosis pathway in a human hepatoma cell line (HepG2).
Garcia A; Barbaras R; Collet X; Bogyo A; Chap H; Perret B
Biochemistry; 1996 Oct; 35(40):13064-71. PubMed ID: 8855942
[TBL] [Abstract][Full Text] [Related]
5. Conformation and lipid binding of the N-terminal (1-44) domain of human apolipoprotein A-I.
Zhu HL; Atkinson D
Biochemistry; 2004 Oct; 43(41):13156-64. PubMed ID: 15476409
[TBL] [Abstract][Full Text] [Related]
6. Combined N- and C-terminal truncation of human apolipoprotein A-I yields a folded, functional central domain.
Beckstead JA; Block BL; Bielicki JK; Kay CM; Oda MN; Ryan RO
Biochemistry; 2005 Mar; 44(11):4591-9. PubMed ID: 15766290
[TBL] [Abstract][Full Text] [Related]
7. Lipid-binding studies of human apolipoprotein A-I and its terminally truncated mutants.
Fang Y; Gursky O; Atkinson D
Biochemistry; 2003 Nov; 42(45):13260-8. PubMed ID: 14609337
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of lipid-binding properties of the N-terminal helical segments in human apolipoprotein A-I using fragment peptides.
Tanaka M; Tanaka T; Ohta S; Kawakami T; Konno H; Akaji K; Aimoto S; Saito H
J Pept Sci; 2009 Jan; 15(1):36-42. PubMed ID: 19048603
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 60 is a high-affinity high-density lipoprotein binding protein.
Bocharov AV; Vishnyakova TG; Baranova IN; Remaley AT; Patterson AP; Eggerman TL
Biochem Biophys Res Commun; 2000 Oct; 277(1):228-35. PubMed ID: 11027668
[TBL] [Abstract][Full Text] [Related]
10. Relevance of the amino acid conversions L144R (Zaragoza) and L159P (Zavalla) in the apolipoprotein A-I binding site for haptoglobin.
Cigliano L; D'Andrea LD; Maresca B; Serino M; Carlucci A; Salvatore A; Spagnuolo MS; Scigliuolo G; Pedone C; Abrescia P
Biol Chem; 2008 Nov; 389(11):1421-6. PubMed ID: 18783334
[TBL] [Abstract][Full Text] [Related]
11. A mass spectrometric determination of the conformation of dimeric apolipoprotein A-I in discoidal high density lipoproteins.
Silva RA; Hilliard GM; Li L; Segrest JP; Davidson WS
Biochemistry; 2005 Jun; 44(24):8600-7. PubMed ID: 15952766
[TBL] [Abstract][Full Text] [Related]
12. Degradation of pre-beta-high density lipoproteins and their binding activity to human blood monocytes.
Nakabayashi T; Yamauchi K; Sugano M; Sano K; Tozuka M; Hidaka H
Ann Clin Lab Sci; 2004; 34(3):287-98. PubMed ID: 15487703
[TBL] [Abstract][Full Text] [Related]
13. Identity of the amino acid residues involved in C3bi binding to the I-domain supports a mosaic model to explain the broad ligand repertoire of integrin alpha M beta 2.
Ustinov VA; Plow EF
Biochemistry; 2005 Mar; 44(11):4357-64. PubMed ID: 15766265
[TBL] [Abstract][Full Text] [Related]
14. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
[TBL] [Abstract][Full Text] [Related]
15. Spectroscopic determination of the binding affinity of zinc to the DNA-binding domains of nuclear hormone receptors.
Payne JC; Rous BW; Tenderholt AL; Godwin HA
Biochemistry; 2003 Dec; 42(48):14214-24. PubMed ID: 14640689
[TBL] [Abstract][Full Text] [Related]
16. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI
Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988
[TBL] [Abstract][Full Text] [Related]
17. Identification and structural ramifications of a hinge domain in apolipoprotein A-I discoidal high-density lipoproteins of different size.
Maiorano JN; Jandacek RJ; Horace EM; Davidson WS
Biochemistry; 2004 Sep; 43(37):11717-26. PubMed ID: 15362856
[TBL] [Abstract][Full Text] [Related]
18. Specific binding of free apolipoprotein A-I to a high-affinity binding site on HepG2 cells: characterization of two high-density lipoprotein sites.
Barbaras R; Collet X; Chap H; Perret B
Biochemistry; 1994 Mar; 33(8):2335-40. PubMed ID: 8117691
[TBL] [Abstract][Full Text] [Related]
19. ABCA1-induced cell surface binding sites for ApoA-I.
Vedhachalam C; Ghering AB; Davidson WS; Lund-Katz S; Rothblat GH; Phillips MC
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1603-9. PubMed ID: 17478755
[TBL] [Abstract][Full Text] [Related]
20. Structural and dynamic features of apolipoprotein A-I cysteine mutants, Milano and Paris, in synthetic HDL.
Rocco AG; Sensi C; Gianazza E; Calabresi L; Franceschini G; Sirtori CR; Eberini I
J Mol Graph Model; 2010 Nov; 29(3):406-14. PubMed ID: 20869895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
